Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: Activation of dual specificity phosphatase

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 1, 2013, Pages 106-114

  Okami, Nobuya ^a   Narasimhan, Purnima ^a   Yoshioka, Hideyuki ^a   Sakata, Hiroyuki ^a   Kim, Gab Seok ^a   Jung, Joo Eun ^a   Maier, Carolina M ^a   Chan, Pak H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c Jun N terminal kinase; cerebral ischemia; dual specificity phosphatase 8; p38 mitogen activated protein kinase; rosiglitazone

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CASPASE 3; LACTATE DEHYDROGENASE; MESSENGER RNA; PHOSPHATASE; ROSIGLITAZONE; SPECTRIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; IMMUNOREACTIVITY; MOUSE; NEUROPROTECTION; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSIENT ISCHEMIC ATTACK; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; DISEASE MODELS, ANIMAL; DUAL-SPECIFICITY PHOSPHATASES; ENZYME ACTIVATION; GLUCOSE; ISCHEMIC ATTACK, TRANSIENT; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; OXYGEN; PHOSPHORYLATION; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLIDINEDIONES;

EID: 84871926261     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.138     Document Type: Article

References (32)

1. Ji S, Kronenberg G, Balkaya M, Färber K, Gertz K, Kettenmann H et al. Acuteneuroprotection by pioglitazone after mild brain ischemia without effect onlong-term outcome. Exp Neurol 2009; 216: 321-328.
2. Wang CX, Ding X, Noor R, Pegg C, He C, Shuaib A. Rosiglitazone alone or incombination with tissue plasminogen activator improves ischemic brain injury inan embolic model in rats. J Cereb Blood Flow Metab 2009; 29: 1683-1694.
3. White AT, Murphy AN. Administration of thiazolidinediones for neuroprotection inischemic stroke: a pre-clinical systematic review. J Neurochem 2010; 115: 845-853.
4. Irving EA, Bamford M. Role of mitogen-and stress-activated kinases in ischemicinjury. J Cereb Blood Flow Metab 2002; 22: 631-647. (Pubitemid 34596455)
5. Borsello T, Clarke PGH, Hirt L, Vercelli A, Repici M, Schorderet DF et al. A peptideinhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebralischemia. Nat Med 2003; 9: 1180-1186. (Pubitemid 37173703)
6. Piao CS, Kim J-B, Han P-L, Lee J-K. Administration of the p38 MAPK inhibitorSB203580 affords brain protection with a wide therapeutic window against focalischemic insult. J Neurosci Res 2003; 73: 537-544. (Pubitemid 36944846)
7. Gao Y, Signore AP, Yin W, Cao G, Yin X-M, Sun F et al. Neuroprotection againstfocal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuationof the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab2005; 25: 694-712. (Pubitemid 40705605)
8. Patterson KI, Brummer T, O'Brien PM, Daly RJ. Dual-specificity phosphatases: criticalregulators with diverse cellular targets. Biochem J 2009; 418: 475-489.
9. Martell KJ, Seasholtz AF, Kwak SP, Clemens KK, Dixon JE. hVH-5: a protein tyrosinephosphatase abundant in brain that inactivates mitogen-activated protein kinase.J Neurochem 1995; 65: 1823-1833.
10. Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A.Rosiglitazone, a peroxisome proliferator-activated receptor-g, inhibits the JunNH2-terminal kinase/activating protein 1 pathway and protects the heart fromischemia/reperfusion injury. Diabetes 2002; 51: 1507-1514. (Pubitemid 34826618)
11. Yoon S-Y, Park J-S, Choi J-E, Choi J-M, Lee W-J, Kim S-W et al. Rosiglitazone reducestau phosphorylation via JNK inhibition in the hippocampus of rats with type 2diabetes and tau transfected SH-SY5Y cells. Neurobiol Dis 2010; 40: 449-455.
12. Jung JE, Kim GS, Narasimhan P, Song YS, Chan PH. Regulation of Mn-superoxidedismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia.J Neurosci 2009; 29: 7003-7014.
13. Niizuma K, Endo H, Nito C, Myer DJ, Kim GS, Chan PH. The PIDDosome mediatesdelayed death of hippocampal CA1 neurons after transient global cerebralischemia in rats. Proc Natl Acad Sci USA 2008; 105: 16368-16373.
14. Chen H, Song YS, Chan PH. Inhibition of NADPH oxidase is neuroprotective afterischemia-reperfusion. J Cereb Blood Flow Metab 2009; 29: 1262-1272.
15. Keyse SM. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. CancerMetastasis Rev 2008; 27: 253-261.
16. Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE. Peroxisomeproliferator-activated receptor-g ligands reduce inflammation andinfarction size in transient focal ischemia. Neuroscience 2005; 130: 685-696. (Pubitemid 39601441)
17. Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S et al. Neuroprotection againstfocal ischemic brain injury by the peroxisome proliferator-activated receptor-gagonist rosiglitazone. J Neurochem 2006; 97: 435-448.
18. Pereira MP, Hurtado O, Cárdenas A, Boscá L, Castillo J, Dávalos A et al. Rosiglitazoneand 15-deoxy-D12,14-rostaglandin J2 cause potent neuroprotection afterexperimental stroke through noncompletely overlapping mechanisms. J CerebBlood Flow Metab 2006; 26: 218-229. (Pubitemid 43151578)
19. Zhao Y, Patzer A, Herdegen T, Gohlke P, Culman J. Activation of cerebral peroxisomeproliferator-activated receptors gamma promotes neuroprotection byattenuation of neuronal cyclooxygenase-2 overexpression after focal cerebralischemia in rats. FASEB J 2006; 20: 1162-1175. (Pubitemid 44943912)
20. Sobrado M, Pereira MP, Ballesteros I, Hurtado O, Fernández- López D, Pradillo JMet al. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARg-dependent,neuroprotective effects of rosiglitazone in experimental stroke. J Neurosci 2009;29: 3875-3884.
21. Shimazu T, Inoue I, Araki N, Asano Y, Sawada M, Furuya D et al. A peroxisomeproliferator-activated receptor-g agonist reduces infarct size in transient but notin permanent ischemia. Stroke 2005; 36: 353-359. (Pubitemid 40170822)
22. Schock SC, Xu J, Duquette PM, Qin Z, Lewandowski AJ, Rai PS et al. Rescue ofneurons from ischemic injury by peroxisome proliferator-activated receptor-grequires a novel essential cofactor LM04. J Neurosci 2008; 28: 12433-12444.
23. Wu J-S, Cheung W-M, Tsai Y-S, Chen Y-T, Fong W-H, Tsai H-D et al. Ligandactivatedperoxisome proliferator-activated receptor-g protects against ischemiccerebral infarction and neuronal apoptosis by 14-3-3e upregulation. Circulation2009; 119: 1124-1134.
24. Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C et al. Modulationof the oxidative stress and inflammatory response by PPAR-g agonists in thehippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol2006; 530: 70-80. (Pubitemid 43037126)
25. Vemuganti R. Therapeutic potential of PPARg activation in stroke. PPAR Res 2008;2008: 461981.
26. Lin T-N, Cheung W-M, Wu J-S, Chen J-J, Lin H, Chen J-J et al. 15d-rostaglandin J2protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol2006; 26: 481-487.
27. Okuno S, Saito A, Hayashi T, Chan PH. The c-Jun N-terminal protein kinase signalingpathway mediates Bax activation and subsequent neuronal apoptosisthrough interaction with Bim after transient focal cerebral ischemia. J Neurosci2004; 24: 7879-7887. (Pubitemid 39215692)
28. Nito C, Kamada H, Endo H, Niizuma K, Myer DJ, Chan PH. Role of the p38 mitogenactivatedprotein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J CerebBlood Flow Metab 2008; 28: 1686-1696.
29. Pearson G, Robinson F, Beers Gibson T, Xu B-E, Karandikar M, Berman K et al.Mitogen-activated protein (MAP) kinase pathways: regulation and physiologicalfunctions. Endocr Rev 2001; 22: 153-183. (Pubitemid 32458157)
30. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease.Nat Rev Mol Cell Biol 2006; 7: 833-846. (Pubitemid 44627477)
31. Pulido R, Hooft van Huijsduijnen R. Protein tyrosine phosphatases: dual-specificityphosphatases in health and disease. FEBS J 2008; 275: 848-866. (Pubitemid 351230203)
32. Koga S, Kojima S, Kishimoto T, Kuwabara S, Yamaguchi A. Over-expression of mapkinase phosphatase-1 (MKP-1) suppresses neuronal death through regulating JNKsignaling in hypoxia/re-oxygenation. Brain Res 2012; 1436: 137-146.